Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Khadija Abdulkarim"'
Publikováno v:
European Journal of Haematology. 98:577-583
Objective The study mainly aimed at investigating possible correlations between peripheral blood counts, erythropoietin (EPO), JAK2 V617F mutation, and vascular complications prior to diagnosis of a population-based cohort of newly diagnosed patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45c1f89a8638fdcbaa1269881c6a07e7
https://doi.org/10.1111/ejh.12873
https://doi.org/10.1111/ejh.12873
Autor:
Morgane Mounier, Bjorn Andreasson, François Girodon, Khadija Abdulkarim, Peter Johansson, Marc Maynadié, Cédric Rossi, Gilles Bonicelli, Valérie Jooste
Publikováno v:
British Journal of Haematology. 160:251-254
Three hundred and twenty-seven patients from two population-based cohorts with an established diagnosis of polycythaemia vera were studied for prognostic risk factors for survival and leukaemia in a long-term survey. The relative survival (RS) was 72
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2255592137d19aaee4ce7187c6a06f8b
https://doi.org/10.1111/bjh.12117
https://doi.org/10.1111/bjh.12117
Autor:
Khadija Abdulkarim, Soodabeh Safai-Kutti, Jack Kutti, Peter Johansson, Bjorn Andreasson, Börje Ridell
Publikováno v:
European Journal of Haematology. 86:148-155
The Philadelphia chromosome-negative (Ph-) chronic myeloproliferative neoplasms include the three well-known clinical entities polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). Over time, patients with ET and PV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a4504b36ac0784530fa1666a15124cd
https://doi.org/10.1111/j.1600-0609.2010.01548.x
https://doi.org/10.1111/j.1600-0609.2010.01548.x
Autor:
Bjorn Andreasson, Sven Schwemmers, Cornelius F. Waller, Heike L. Pahl, Peter Johansson, Khadija Abdulkarim, Britta Will
Publikováno v:
Experimental Hematology. 35:1695-1703
Objective Presence of the JAK2 V617F mutation in only 40% to 60% of patients with essential thrombocythemia (ET) underscores the heterogeneity of this myeloproliferative disorder (MPD). Several distinct mutations, either in JAK2 (exon 12) or in c-Mpl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8de06e03741479b28a96dcdeae52492
https://doi.org/10.1016/j.exphem.2007.07.004
https://doi.org/10.1016/j.exphem.2007.07.004
Autor:
Khadija, Abdulkarim, Börje, Ridell, Peter, Johansson, Jack, Kutti, Soodabeh, Safai-Kutti, Björn, Andréasson
Publikováno v:
European journal of haematology. 86(2)
The Philadelphia chromosome-negative (Ph-) chronic myeloproliferative neoplasms include the three well-known clinical entities polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). Over time, patients with ET and PV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::66d30d4c7d57c5656539f12f12ba56df
https://pubmed.ncbi.nlm.nih.gov/21059102
https://pubmed.ncbi.nlm.nih.gov/21059102
Autor:
Khadija Abdulkarim, Emeline Bovet, Paule-Marie Carli, Peter Johansson, Jack Kutti, François Girodon, Bjorn Andreasson, Marc Maynadié
Publikováno v:
European journal of haematology. 82(2)
The Philadelphia chromosome-negative (Ph-) chronic myeloproliferative disorders (MPD) have an inherent tendency for transformation into acute myelogenous leukaemia (AML). The long-term rate of leukaemic transformation in unselected MPD patients was s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e87d6b941a3ed346fb6f0bd0bd152fe3
https://pubmed.ncbi.nlm.nih.gov/19134023
https://pubmed.ncbi.nlm.nih.gov/19134023
Autor:
Sven, Schwemmers, Britta, Will, Cornelius F, Waller, Khadija, Abdulkarim, Peter, Johansson, Björn, Andreasson, Heike L, Pahl
Publikováno v:
Experimental hematology. 35(11)
Presence of the JAK2V617F mutation in only 40% to 60% of patients with essential thrombocythemia (ET) underscores the heterogeneity of this myeloproliferative disorder (MPD). Several distinct mutations, either in JAK2 (exon 12) or in c-Mpl (W515L) ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f7f417ca5d97dab75aefbd5c013fd77d
https://pubmed.ncbi.nlm.nih.gov/17764814
https://pubmed.ncbi.nlm.nih.gov/17764814
Autor:
Peter Johansson, Gilles Bonicelli, Morgane Mounier, Khadija Abdulkarim, François Girodon, Marc Maynadié, Bjorn Andreasson, Valérie Jooste
Publikováno v:
Blood. 118:2819-2819
Abstract 2819 Introduction Polycythemia Vera (PV) is a myeloproliferative neoplasm with a long life expectancy. Consequently, long-term follow-up studies that focus on survival of PV patients must be conducted in order to register a sufficient number
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42d22e9d747607956c35c9a862a4527d
https://doi.org/10.1182/blood.v118.21.2819.2819
https://doi.org/10.1182/blood.v118.21.2819.2819